HONG KONG, Apr 1, 2025 – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus Medtech” or the “Company”, stock code: 6922.HK), announced its annual results for the year ended 31 December 2024 (the “Reporting Period”). In 2024, Cryofocus Medtech achieved a total revenue of RMB53.5 million, an increase of 30.7% year-over-year (“YoY”…
Read More
